NEDA as a predictor of conversion to secondary progressive multiple sclerosis in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Kappos, L. [1 ,2 ,3 ,4 ]
Stefano, N. D. [5 ]
Sormani, M. P. [6 ]
Giovannoni, G. [7 ]
Haring, D. [8 ]
Tomic, D. [8 ]
Meier, D. Piani [8 ]
Chitnis, T. [9 ]
机构：
[1] Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland
[2] Univ Basel Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland
[3] Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland
[4] Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland
[5] Univ Siena, Siena, Italy
[6] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy
[7] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[8] Novartis Pharma AG, Basel, Switzerland
[9] Massachusetts Gen Hosp, Partners Pediat Multiple Sclerosis Ctr, Boston, MA 02114 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1217
引用
收藏
页码：638 / 639
页数：2
相关论文
共 50 条
  • [41] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [42] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [43] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [44] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [45] Patient-reported physical functioning in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients in Europe
    Jones, E.
    Naoshy, S.
    Pike, J.
    Watson, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 754 - 754
  • [46] Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
    Herman, Stephanie
    Akerfeldt, Torbjorn
    Spjuth, Ola
    Burman, Joachim
    Kultima, Kim
    CELLS, 2019, 8 (02)
  • [47] A TYPE 2 BIOMARKER SEPARATES RELAPSING-REMITTING FROM SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
    Gilbert, Gordon J.
    NEUROLOGY, 2015, 84 (21) : 2201 - 2201
  • [48] Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis
    Elzamarany, Eman
    Afifi, Lamia
    El-Fayoumy, Neveen M.
    Salah, Husam
    Nada, Mona
    ACTA NEUROLOGICA BELGICA, 2016, 116 (02) : 145 - 150
  • [49] Urine levels of 8-Isoprostane in relapsing-remitting and secondary progressive multiple sclerosis
    Kivisaekk, P.
    Hyvert, Y.
    Melo, K.
    Cook, S.
    Chitnis, T.
    Weiner, H. L.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 183 - 183
  • [50] A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
    Dickens, Alex M.
    Larkin, James R.
    Griffin, Julian L.
    Cavey, Ana
    Matthews, Lucy
    Turner, Martin R.
    Wilcock, Gordon K.
    Davis, Benjamin G.
    Claridge, Timothy D. W.
    Palace, Jacqueline
    Anthony, Daniel C.
    Sibson, Nicola R.
    NEUROLOGY, 2014, 83 (17) : 1492 - 1499
12345